Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidel

Showing results (421-430 of 715) with videos related to

Pageof 72
Sort By:
The American Journal of Pathology|March 1, 1989
In vivo chemotaxis of bovine neutrophils induced by 5-lipoxygenase metabolites of arachidonic and eicosapentaenoic acidJ R Heidel, S M Taylor, W W Laegreid, et al.
Biochemistry and Biophysics Reports|March 28, 2017
Secondary structure propensity and chirality of the amyloidophilic peptide p5 and its analogues impacts ligand binding - <i>In vitro</i> characterizationJonathan S Wall, Angela Williams, Craig Wooliver, et al.
Bone Marrow Transplantation|March 26, 2022
Significance of men's health in long-term survivors of allogeneic stem cell transplantationLaila Schneidewind, Thomas Neumann, Nadette Peters, et al.
Journal of Hematology & Oncology|June 14, 2013
Rapid induction of complete molecular remission by sequential therapy with LDAC and sorafenib in FLT3-ITD-positive patients unfit for intensive treatment: two cases and review of the literatureDenise Wolleschak, Enrico Schalk, Christian Krogel, et al.
Leukemia|March 30, 2026
Differential mitochondrial priming by BCR::ABL1 in B-cell precursor acute lymphoblastic leukemiaHanna Kirchhoff, Caroline Schoenherr, Lisa Fleischer, et al.
Palliative & Supportive Care|November 18, 2022
Comparison of inpatient and outpatient palliative sedation practice - A prospective observational studyBritta Buchhold, Andreas Jülich, Franziska Glöckner, et al.
Journal of Cancer Research and Clinical Oncology|January 20, 2026
Patient-reported outcomes regarding the use of complementary and alternative medicine (CAM) in BCR::ABL1-negative myeloproliferative neoplasiasCarl C Crodel, Charlotte Kohnle, Markus P Radsak, et al.
Antioxidants (Basel, Switzerland)|March 25, 2022
Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia CellsMuhammed Burak Demircan, Peter C Mgbecheta, Anne Kresinsky, et al.
Leukemia Research|June 17, 2008
The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemiaStefan Kasper, Frank Breitenbuecher, Yvette Hoehn, et al.
Journal of Surgical Education|January 20, 2019
Evaluating and Exploring Variations in Surgical Resident Emotional Intelligence and BurnoutShannon P Beierle, Baileigh A Kirkpatrick, Robert Eric Heidel, et al.
Pageof 72

Showing results (421-430 of 715) with videos related to

Sort By:
Pageof 72
The American Journal of Pathology|March 1, 1989
In vivo chemotaxis of bovine neutrophils induced by 5-lipoxygenase metabolites of arachidonic and eicosapentaenoic acidJ R Heidel, S M Taylor, W W Laegreid, et al.
Biochemistry and Biophysics Reports|March 28, 2017
Secondary structure propensity and chirality of the amyloidophilic peptide p5 and its analogues impacts ligand binding - <i>In vitro</i> characterizationJonathan S Wall, Angela Williams, Craig Wooliver, et al.
Bone Marrow Transplantation|March 26, 2022
Significance of men's health in long-term survivors of allogeneic stem cell transplantationLaila Schneidewind, Thomas Neumann, Nadette Peters, et al.
Journal of Hematology & Oncology|June 14, 2013
Rapid induction of complete molecular remission by sequential therapy with LDAC and sorafenib in FLT3-ITD-positive patients unfit for intensive treatment: two cases and review of the literatureDenise Wolleschak, Enrico Schalk, Christian Krogel, et al.
Leukemia|March 30, 2026
Differential mitochondrial priming by BCR::ABL1 in B-cell precursor acute lymphoblastic leukemiaHanna Kirchhoff, Caroline Schoenherr, Lisa Fleischer, et al.
Palliative & Supportive Care|November 18, 2022
Comparison of inpatient and outpatient palliative sedation practice - A prospective observational studyBritta Buchhold, Andreas Jülich, Franziska Glöckner, et al.
Journal of Cancer Research and Clinical Oncology|January 20, 2026
Patient-reported outcomes regarding the use of complementary and alternative medicine (CAM) in BCR::ABL1-negative myeloproliferative neoplasiasCarl C Crodel, Charlotte Kohnle, Markus P Radsak, et al.
Antioxidants (Basel, Switzerland)|March 25, 2022
Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia CellsMuhammed Burak Demircan, Peter C Mgbecheta, Anne Kresinsky, et al.
Leukemia Research|June 17, 2008
The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemiaStefan Kasper, Frank Breitenbuecher, Yvette Hoehn, et al.
Journal of Surgical Education|January 20, 2019
Evaluating and Exploring Variations in Surgical Resident Emotional Intelligence and BurnoutShannon P Beierle, Baileigh A Kirkpatrick, Robert Eric Heidel, et al.
Pageof 72